Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      MDCPartners Introduces Medical Expert Search Tool for Biopharma with New “Podium” App

      Americas
      MDCPartners introduces Podium, an online application for Clinical Ops, Medical Affairs teams and Medical Science Liaisons. The technology is based on the organization’s well-known...

      ChemAxon Software is Integrated into ChemPass’s Novel Drug Design Platform

      Americas
      ChemAxon and ChemPass, jointly announce that several ChemAxon software components and toolkits are incorporated into ChemPass' artificial intelligence design technology platform; and also, into...

      Scientists Create Successful Mass Production System for Bioengineered Livers

      Americas
      Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic transplant into people. A team...

      Mylan and Aspen Announce Launch of Generic Busulfex® Injection

      Americas
      Mylan N.V. and its partner, Aspen announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version...

      Triphase Accelerator To Present Investigational New Drug Enabling Data For TRPH-222

      Americas
      Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider of...

      Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation

      Americas
      Grifols , a leading global producer of plasma-derived medicines and provider of sterile compounding-related technologies and services for hospitals, clinics, and compounding centers, has...

      Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting

      Americas
      Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a clinical-stage biopharmaceutical company, today announced the presentation of a scientific poster entitled “Selective Inhibitors Suggest Nav1.6 Activity is the...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.